Ultrastructural studies in stable vitiligo

American Journal of Dermatopathology

Volumn 25, Issue 1, 2003, Pages 16-20

  Panuncio, Ana L ^a,b   Vignale, R ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b NONE   (Uruguay)

Author keywords

Keratinocyte; Langerhans cells; Melanocyte; Ultrastructure; Vitiligo

Indexed keywords

ARTICLE; CASE REPORT; CELL ACTIVITY; CELL ULTRASTRUCTURE; CYTOTOXICITY; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LANGERHANS CELL; LICHENOID ERUPTION; LYMPHOCYTE; MACROPHAGE; MALE; MELANOCYTE; PRIORITY JOURNAL; SEBACEOUS GLAND; SKIN BIOPSY; VITILIGO;

ADULT; FEMALE; HUMANS; KERATINOCYTES; LANGERHANS CELLS; MALE; MELANOCYTES; MICROSCOPY, ELECTRON; MIDDLE AGED; VITILIGO;

EID: 0037306078     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200302000-00004     Document Type: Article

References (32)

1. Nordlund JJ. Vitiligo: is it important? Arch Dermatol 1982;118:5-8.
2. Ortonne J-P, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanoses of hair and skin. New York: Plenum Medical Books, 1983:129-310.
3. Ortonne JP, Bose SK. Vitiligo: where do we stand? Pigment Cell Res 1993;6:61-72.
4. Vignale R, Paciel J, Calandria L. Alteraciones immunológicas en el vitiligo vulgar. Med Cutan Ibero Lat Am 1988;16:343-47.
5. le Poole IC, Das PK, van der Wijngaard R, et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993;2:145-53.
6. Yu HS, Kao CH, Yu CL. Coexistence of and relationship of anti-keratinocyte and antimelanocyte antibodies in patients with non-segmental-type-vitiligo. J Invest Dermatol 1993;100:823-8.
7. Grimes PE, Stockton T, Payne C, et al. T cell profiles in vitiligo. J Am Acad Dermatol 1986;14:196-201.
8. van der Wijngaard R, Wankowicz-Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients: destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000;80:1299-309.
9. Palermo B, Campanelli R, Garbelli S, et al. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J Invest Dermatol 2001;117:326-32.
10. Spielvogel RL, Kantor GR. Vitiligo: pigmentary disorders of the skin. In: Elder D, ed. Lever's histopathology of the skin. 8th ed. Philadelphia: Lippincott. 1997:620.
11. Perrot H, Ortonne JP, Schmitt D. Etude ultrastructural du vitiligo. Lyon Med 1974;232:439-46.
12. Moellmann G, Klein-Angerer S, Scollay DA, et al. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982;79:321-30.
13. Bhawan J, Bhutani LK. Keratinocyte damage in vitiligo. J Cutan Pathol 1983;10:207-12.
14. Hann SK, Park YK, Lee KG, et al. Epidermal changes in active vitiligo. J Dermatol 1992;19:217-22.
15. Galadari E, Mehregan AH, Hashimoto K. Ultrastructural study of vitiligo. Int J Dermatol 1993;32:269-71.
16. Le Poole IC, van der Wijngaard RM, Westerhof W, et al. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996;148:1219-28.
17. Bartosik J, Wulf HCh, Kobayasi T. Melanin and melanosome complexes in long standing stable vitiligo-an ultrastructural study. Eur J Dermatol 1998;8:95-7.
18. Hann S-K, Kim Y-S, Yoo JH, et al. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol 2000;42:589-96.
19. Birbeck MS, Breathnach AS, Everall JD. An electron microscopic study on basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 1961;37:51-64.
20. Breathnach AS, Bor S, Wyllie LMA. Electron microscopy of peripheral nerve terminals and marginal melanocytes in vitiligo. J Invest Dermatol 1966;47:125-40.
21. Gonçalvez RP, Bechelli LM, Trad ES, Zanin LC. Étude quantitative ultraestructurale de la couche basal de l'epiderme dans les taches de vitiligo, dans la mélanodermie périlésionelle et la peau normale marginale. Ann Dermatol Venereol 1978;105:395-400.
22. Kano Y, Shiohara T, Nagashima M. Epidermal Langerhans cells in various skin diseases (2): Langerhans cells in vitiligo. J Dermatol 1984;11:103-10.
23. Claudy AL, Rouchouse B. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells. Acta Derm Venereol (Stockh) 1984;64:334-6.
24. Hatchome N, Aiba S, Kato T, et al. Possible functional impairment of Langerhans' cells in vitiliginous skin. Arch Dermatol 1987;123:51-4.
25. Kao Ch-H, Yu H-S. Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo. J Dermatol 1990;17:287-96.
26. Brown J, Winkelmann RK, Wolff K. Langerhans cells in vitiligo: a quantitative study. J Invest Dermatol 1967;49:386-90.
27. Breathnach AS. An atlas of ultrastructure of human skin. In: Breathnach AS, ed. First ed. London: Churchill, 1971:138.
28. Le Poole IC, van den Wijngaard RN, Westerhof W, Dutrieux RP, Das PK. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993;100:816-22.
29. Tobin DJ, Swanson NN, Pittelkow MR, et al. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000;191:407-16.
30. Arrunategui, A, Arroyo C, Garcia L, et al. Melanocyte reservoir in vitiligo, Int J Dermatol 1994;33:484-7.
31. Ortonne JP, MacDonald DM, Micoud A, Thivolet J. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol 1979;101:1-12.
32. Toussaint S, Kamino H. Non infectious erythematous, papular and squamous diseases. In: Lever's histopathology of the skin. In: Elder D, ed. Lever's histopathology of the skin. 8th ed. Philadelphia: Lippincott, 1997:151-252.